PATENT CLAIM ANALYSIS

Application Number: 16022577
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "093400"]

Abstract:
The invention provides compositions comprising one or more bacterial strains for use in a method of reducing the level of Enterobacteriaceae in the gastrointestinal tract.

Claim (Index 3):
The composition of  claim 1 , wherein the composition is for use in a method of reducing the level of Enterobacteriaceae in the gastrointestinal tract in the treatment or prevention of IBS, Crohn's disease, ulcerative colitis, functional dyspepsia, diarrhoea, gastroenteritis, urinary tract infection or neonatal meningitis.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.13043
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15916205', '15915885', '16022207', '15915889', '16022256']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8100704074154483
- 35 USC 102 Novelty (BERT): 0.6700257641518165
- Combined Prediction Score: 0.7960659430890851
- Mean Citation Score: 680.5063899999999
- Max Citation Score: 775.2112
- Similarity Product: 538.3776858760833

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test